- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Video
Key Takeaways and Discussion Highlights
Author(s):
Drs Justine Cohen and Brent Moody provide their key takeaways and panel discussion highlights related to the management of patients with basal cell carcinoma.
Video Player is loading.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Apoptosis-Based Skin Cancer Treatment Shows Promise
Data Review of 2 doses of Sonidegib in Advanced Basal Cell Carcinoma (BOLT Trial)
Expert Perspectives on EVRIANCE clinical trial data
Data Review of the Efficacy and Safety of Vismodegib in Advanced Basal Cell Carcinoma (EVRIANCE Trial)
Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma
Expert Insights Into Locally Advanced Basal Cell Carcinoma
Management of Newly Diagnosed Patients with Basal Cell Carcinoma (BCC)
Treatment Considerations and Management of Adverse Events when Treating BCC
Efficacy and Safety of Combination Treatments for BCC
Developing a Multidisciplinary Approach when Treating BCC
Related Content
